Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia

Journal of Diabetes Investigation

Volumn 1, Issue 5, 2010, Pages 202-207

  Koga, Masafumi ^a   Murai, Jun ^a   Saito, Hiroshi ^a   Mukai, Mikio ^a   Kasayama, Soji ^b  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b NISSAY HOSPITAL   (Japan)

Author keywords

Glycated albumin; Glycated hemoglobin; Triglyceride

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 77957737496     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2010.00049.x     Document Type: Article

References (30)

1. Cohen MP. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J Diabet Complications 1998; 2: 214-217.
2. Koenig RJ, Peterson CM, Jones RL, et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976; 295: 417-420.
3. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 20: 21-27.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004; 21: 657-665.
6. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001; 47: 153-163.
7. 1C) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007; 54: 139-144.
8. Guthrow CE, Morris MA, Day JF, et al. Enhanced nonenzy-matic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979; 76: 4258-4261.
9. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007; 18: 896-903.
10. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008; 7: 1062-1068.
11. Hashimoto K, Noguchi S, Morimoto Y, et al. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care 2008; 31: 1945-1948.
12. Koga M. Glycated albumin and fructosamine. Sogo Rinsho 2008; 57: 1922-1927 (Japanese).
13. Koga M, Kasayama S, Kanehara H, et al. CLD (chronic liver disease)-HbA1c as a novel indicator for estimation of mean plasma glucose in the patients with chronic liver disease. Diabetes Res Clin Pract 2008; 81: 258-262.
14. Koga M, Murai J, Saito H, et al. Effect of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res Clin Pract 2009; 84: 141-144.
15. Nishimura R, Kanda A, Sano H, et al. Glycated albumin is low in obese, non-diabetic children. Diabetes Res Clin Pract 2006; 71: 334-338.
16. Koga M, Matsumoto S, Saito H, et al. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 2006; 53: 387-391.
17. Koga M, Otsuki M, Matsumoto S, et al. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta 2007; 378: 48-52.
18. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985; 153: 9-13.
19. Koga M, Saito H, Mukai M, et al. Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetol 2009; 46: 141-144.
20. Koga M, Murai J, Saito H, et al. Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in hyperuricemic men. Acta Diabetol, 2009. doi: 10.1007/s00592-009-0168-6
21. Lundman P, Eriksson MJ, Silveira A, et al. Relation of hypertri-glyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation. Am J Cardiol 2003; 91: 1128-1131.
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
23. 1C with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem 2005; 38: 88-91.
24. Kouzuma T, Uemastu Y, Usami T, et al. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta 2004; 346: 135-143.
25. Hashimoto K, Kasayama S, Yamamoto H, et al. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 2004; 21: 581-585.
26. Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous for fat obesity. Metabolism 1998; 47: 929-933.
27. Tsouli SG, Liberopoulos EN, Mikhailidis DP, et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006; 55: 1293-1301.
28. Currie CJ, Poole CD, Papo NL. An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes. Curr Med Res Opin 2009; 25: 2389-2400.
29. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64-80.
30. Fruchart JC, Nierman MC, Stroes ES, et al. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004; 109(23 Suppl 1): III15-III19.